HIV/AIDS Therapy
Data on HIV/AIDS therapy reported by E. Vispo and co-researchers
Published in Hospital Law Weekly, July 10th, 2008
Scientists discuss in 'Low response to pegylated interferon plus ribavirin in HIV-infected patients with chronic hepatitis C treated with abacavir' new findings in HIV/AIDS. "There is little information about the influence of antiretroviral drugs on the antiviral activity of pegylated interferon (PEG-IFN) plus ribavirin (RBV) against hepatitis C virus (HCV). All HIV-infected patients with chronic hepatitis C who received first-line PEG-IFN plus RBV were retrospectively analyzed," scientists in Madrid, Spain report.
"Only patients in whom virological stopping rules were applied and who did not change their antiretrovirals were chosen. Plasma RBV concentrations were...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly
Source: Hospital Law Weekly (2008-07-10)
More Articles from Hospital Law Weekly
- Ballard Spahr Andrews & Ingersoll, LLP
Ballard Acquires Atlanta IP Group - Business of Birth International
Controversies in Childbirth Conference Draws Broad Interest Across Medical Professions, Across the U.S., and Across the Atlantic - Drug Resistance
Federal Action Needed to Fill Antibiotic Pipeline, Says the Alliance for the Prudent Use of Antibiotics - Eric Drew
Credit Card Companies Fueling Healthcare Associated Identity Theft (HAIT) Crimes - Health Insurance
Potential Blues Merger Poses Concern for Area Health Systems - Heart Disease
Appellate Court Rules That $2.7 Million Heart Transplant Verdict Should Stand - More from this issue of Hospital Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
